Free Trial
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

Health Sciences Acquisitions Co. 2 logo
$5.95 +0.22 (+3.84%)
As of 10/9/2026

About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)

Advanced

Key Stats

Today's Range
$5.56
▼
$5.97
50-Day Range
$3.98
▼
$6.35
52-Week Range
$9.41
▼
$13.80
Volume
229,318 shs
Average Volume
205,918 shs
Market Capitalization
$66.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Health Sciences Acquisitions Co. 2 is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the health care, life sciences, biotechnology, medical technology, or related sectors.

Unlike an operating company, Health Sciences Acquisitions Co. 2 does not manufacture products or provide health care services of its own. Its principal activities involve evaluating potential merger or acquisition candidates and pursuing a transaction that could result in a target company becoming publicly traded.

The company was organized in the United States and raised capital through a public offering for the purpose of pursuing a business combination. Its operations and geographic focus are dependent on the target business ultimately selected, and information about any resulting operating activities would be subject to the completion of such a transaction.

AI Generated. May Contain Errors.

Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HSAQ Stock News Headlines

First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
Quest Completes Acquisition Of Select Laboratory Assets From Allina Health
See More Headlines

HSAQ Stock Analysis - Frequently Asked Questions

Health Sciences Acquisitions Co. 2's stock was trading at $4.15 on January 1st, 2026. Since then, HSAQ shares have increased by 43.4% and is now trading at $5.95.

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering (IPO) on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU).

Company Calendar

Today
10/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:HSAQ
CIK
1814114
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$380 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-2.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.61

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.62) per share
Price / Book
-9.60

Miscellaneous

Outstanding Shares
11,212,000
Free Float
8,757,000
Market Cap
$66.71 million
Optionable
Not Optionable
Beta
0.09
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:HSAQ) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners